Mativ (MATV) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
25 Mar, 2026Business overview and product highlights
Operates in filtration, advanced materials, sustainable and adhesive solutions, serving over 100 countries with $2.0B TTM revenue and $225M TTM adjusted EBITDA as of Q4 FY25.
Product portfolio includes filtration media, tapes, optical films, cable wraps, and specialty papers, with applications in water purification, industrial, healthcare, and packaging.
Filtration & Advanced Materials segment accounts for 39% of net sales, while Sustainable & Adhesive Solutions represents 61%.
Key end markets include industrial (23% of sales), transportation (18%), consumer/advertising (15%/8%), healthcare (15%), and construction (12%).
Products are integral to demanding applications such as HVAC, life sciences, wind turbines, and smart surfaces.
Strategic transformation and operational efficiency
Achieved over $65M in synergies since merger, reduced net debt by over 40%, and right-sized dividend to align with growth orientation.
Divested engineered papers and ceased tobacco exposure, focusing on high-growth end markets and optimizing manufacturing footprint.
Reduced number of warehouses by 25% and ERPs by 30%, streamlining operations and supply chain.
Global manufacturing footprint includes 21 facilities in North America, 10 in Europe, and 3 in Asia Pacific.
Growth investments and innovation
Investing in new production lines for filtration, release liners, specialty tapes, and medical films, with expected incremental revenue of $115M by mid-2026.
Focused on organic growth, product innovation, market adjacencies, strategic cross-selling, and pricing execution.
Dedicated R&D and technology enablement to drive new product development and operational efficiencies.
Latest events from Mativ
- Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Record free cash flow and EBITDA gains achieved despite market headwinds and goodwill impairment.MATV
Q4 202519 Feb 2026 - Adjusted EBITDA rose 13% year-over-year, with margin and cash flow improvements in Q2 2024.MATV
Q2 20242 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026 - SaaS/SAS growth and cost actions offset FAM headwinds, supporting 2025 profit improvement.MATV
Q4 202423 Dec 2025 - All proposals passed, including director election and equity plan amendment; no questions raised.MATV
AGM 202523 Dec 2025 - Board recommends voting FOR all proposals, with focus on governance, compensation, and ESG.MATV
Proxy Filing2 Dec 2025 - Annual meeting to vote on director election, auditor ratification, pay, and equity plan.MATV
Proxy Filing2 Dec 2025